Apogee Therapeutics (APGE) Accounts Payables (2022 - 2026)
Apogee Therapeutics (APGE) reported Accounts Payables of $3.08 million for Q2 2026, down 45.8% from $5.68 million a year earlier but up 149.0% from the prior quarter.
Powered by 
Analysis
Apogee Therapeutics (APGE) Accounts Payables (2022 - 2026) Analysis & Trends
At the end of FY2025, Apogee Therapeutics posted Accounts Payables of $1.22 million, up 14.0% from FY2024.
- Accounts Payables has a three-year compound annual growth rate of 42.9% (FY2022 to FY2025).
- By year, Accounts Payables came in at $1.07 million in FY2024 (-50.0%), $2.14 million in FY2023 (+412.7%) and $418,000 in FY2022.
- Five-year quarterly Accounts Payables spans a low of $376,000 in Q3 2025 and a high of $11.15 million in Q2 2023.
- Year over year, Accounts Payables gained in three of the last eight quarters, with an average decline of 21.4%.
- The high point for year-over-year Accounts Payables in five years was Q4 2023 (growth of 412.7%); the low point was Q3 2025 (a decline of 83.0%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $1.24 million (Q1 2026), $1.22 million (Q4 2025) and $376,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 9.22 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 33.30 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 3.83 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 4.26 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -22.89 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 2.87 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 674.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 4.58 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 429.50 Mn |
| 10 | Apogee Therapeutics | 10.18 Bn | 7.68 Bn | - | 3.08 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.08 Mn |
| Mar 31, 2026 | 1.24 Mn |
| Dec 31, 2025 | 1.22 Mn |
| Sep 30, 2025 | 376,000.00 |
| Jun 30, 2025 | 5.68 Mn |
| Mar 31, 2025 | 2.45 Mn |
| Dec 31, 2024 | 1.07 Mn |
| Sep 30, 2024 | 2.22 Mn |
| Jun 30, 2024 | 5.53 Mn |
| Mar 31, 2024 | 4.30 Mn |
| Dec 31, 2023 | 2.14 Mn |
| Sep 30, 2023 | 1.21 Mn |
| Jun 30, 2023 | 11.15 Mn |
| Dec 31, 2022 | 418,000.00 |
API Access
Apogee Therapeutics Accounts Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accounts-payables&ticker=APGE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accounts-payables", "ticker": "APGE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accounts-payables&ticker=APGE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();